Related Experiment Video
Updated: Jun 21, 2026

Christopher Hughes: An in vitro model for the Study of Angiogenesis (Interview)
Published on: April 28, 2007
An audience with...Joseph Bolen. Interview by Bethan Hughes
Insights
Dr. Joseph Bolen
Area of Science:
- Biochemistry
- Oncology
- Drug Discovery
Background:
- Dr. Bolen's extensive career in oncology spans both academic and industry leadership roles.
- He has held significant positions at major pharmaceutical companies, including Millennium: The Takeda Oncology Company, Hoechst Marion Roussel, and Bristol-Myers Squibb.
- His early research contributions include work in the Biochemical Oncology Department at the National Cancer Institute and the laboratory of tumor virus biology.
Discussion:
- This profile highlights a distinguished career trajectory in cancer research and development.
- It underscores the importance of leadership in driving oncology drug discovery initiatives.
- The narrative emphasizes a blend of foundational scientific research and strategic corporate leadership.
Key Insights:
- A strong foundation in biochemical oncology is crucial for leading drug discovery efforts.
- Experience across academic institutions and pharmaceutical giants provides a comprehensive understanding of the field.
- Leadership roles at companies like Millennium: The Takeda Oncology Company signify impactful contributions to cancer treatment development.
Outlook:
- Continued leadership in oncology is vital for advancing cancer therapies.
- The integration of academic and industrial expertise accelerates innovation in drug discovery.
- Future contributions from seasoned professionals like Dr. Bolen are expected to shape the landscape of cancer treatment.
Abstract:
Chief Scientific Officer, Millennium: The Takeda Oncology Company,Cambridge, Massachusetts, USA. Prior to joining Millennium, Joseph Bolen, Ph.d., held positions including Vice President and Global head of Oncologic diseases at hoechst Marion Roussel, and executive director of oncology drug discovery at the Bristol-Myers Squibb Pharmaceutical Research institute. in addition to other senior academic positions, he was Section Chief of the Biochemical Oncology Department at the National Cancer Institute in Maryland, USA, and a founding member of their laboratory of tumor virus biology.
Related Concept Videos
Journal Bearings
To better understand the concept of journal bearings, consider a rope winch with dry or...
Bystander Effect
Life Histories
The Bell Curve
This pattern applies to many human characteristics beyond intelligence, such as height. For example, if you...
Bearings: Problem Solving
Barriers to Effective Communication II
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...

